AR and prostate cancer: In this study, the interaction of serum nucleases with the mentioned SNA-siRNA-AR was analyzed based on the capacity of knocking down human androgen receptor (AR) expression in lymph node carcinoma of the prostate (LNCaP) for prostate cancer (PC) therapy.